246 related articles for article (PubMed ID: 28107695)
1. Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates.
Swain SS; Paidesetty SK; Padhy RN
Biomed Pharmacother; 2017 Apr; 88():181-193. PubMed ID: 28107695
[TBL] [Abstract][Full Text] [Related]
2. Development of antibacterial conjugates using sulfamethoxazole with monocyclic terpenes: A systematic medicinal chemistry based computational approach.
Swain SS; Paidesetty SK; Padhy RN
Comput Methods Programs Biomed; 2017 Mar; 140():185-194. PubMed ID: 28254074
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel thymol derivatives against MRSA and ESBL producing pathogenic bacteria.
Swain SS; Paidesetty SK; Padhy RN
Nat Prod Res; 2019 Nov; 33(22):3181-3189. PubMed ID: 29792335
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on Antibacterial efficacy of a series of chromone sulfonamide derivatives against drug-resistant and MDR-isolates.
Das Mahapatra A; Patra C; Sepay N; Sinha C; Chattopadhyay D
Braz J Microbiol; 2024 Mar; 55(1):343-355. PubMed ID: 38066229
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of daptomycin against VRE and MRSA strains].
Aktaş G; Derbentli S
Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, anti-MRSA, and anti-VRE activity of hemin conjugates with amino acids and branched peptides.
Okorochenkov SA; Zheltukhina GA; Mirchink EP; Isakova EB; Feofanov AV; Nebolsin VE
Chem Biol Drug Des; 2013 Oct; 82(4):410-7. PubMed ID: 23663365
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity and mechanism of action of Monarda punctata essential oil and its main components against common bacterial pathogens in respiratory tract.
Li H; Yang T; Li FY; Yao Y; Sun ZM
Int J Clin Exp Pathol; 2014; 7(11):7389-98. PubMed ID: 25550774
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
11. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
12. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.
Okamura S; Nishiyama E; Yamazaki T; Otsuka N; Taniguchi S; Ogawa W; Hatano T; Tsuchiya T; Kuroda T
Biochim Biophys Acta; 2015 Jun; 1850(6):1245-52. PubMed ID: 25731981
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure.
Mondal S; Mandal SM; Mondal TK; Sinha C
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():268-79. PubMed ID: 26056977
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of Ag and Cu NPs by secondary metabolites of usnic acid and thymol with biological macromolecules aggregation and antibacterial activities against multi drug resistant (MDR) bacteria.
Alavi M; Karimi N
Int J Biol Macromol; 2019 May; 128():893-901. PubMed ID: 30708006
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli.
Hamoud R; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2014 Mar; 21(4):443-7. PubMed ID: 24262063
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
17. Selenium Nanoparticles as Candidates for Antibacterial Substitutes and Supplements against Multidrug-Resistant Bacteria.
Han HW; Patel KD; Kwak JH; Jun SK; Jang TS; Lee SH; Knowles JC; Kim HW; Lee HH; Lee JH
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356651
[TBL] [Abstract][Full Text] [Related]
18. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
19. [Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis].
León J; Aponte JJ; Rojas R; Cuadra D; Ayala N; Tomás G; Guerrero M
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):237-46. PubMed ID: 21845303
[TBL] [Abstract][Full Text] [Related]
20. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
